SCHEMBL6001055

SCHEMBL6001055

CCC(CC)c1ccc(N(Cc2ccc(-c3ccc(COc4cncc(C(=O)O)c4)s3)cc2)C(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.47
SIRT2 Q8IXJ6 6/20 0.34
SIRT1 Q96EB6 5/20 0.34
SIRT3 Q9NTG7 4/20 0.34
MRGPRX4 Q96LA9 1/20 0.32
MEN1 O00255 1/20 0.32
HTT P42858 1/20 0.32
GFER P55789 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
EP300 Q09472 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
FFAR1 O14842 1/20 0.32
RORC P51449 1/20 0.31
S1PR1 P21453 1/20 0.31
PTPN2 P17706 1/20 0.31
P2RX3 P56373 1/20 0.31
NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001052 0.94 PTPN1 (0.41) PTPN1SIRT2SIRT1SIRT3MRGPRX4
SCHEMBL6001039 0.87 PTPN1 (0.47) PTPN1SIRT2SIRT1SIRT3MEN1
SCHEMBL4730123 0.84 PTPN1 (0.66) PTPN1SIRT2SIRT1SIRT3MRGPRX4
SCHEMBL14260783 0.83 PTPN1 (0.48) PTPN1SIRT2SIRT1SIRT3MRGPRX4
SCHEMBL5999251 0.83 PTPN1 (0.44) PTPN1PTPN2NPC1RAB9A
SCHEMBL4726653 0.83 PTPN1 (0.60) PTPN1SIRT2SIRT1SIRT3MRGPRX4
SCHEMBL6000881 0.81 PTPN1 (0.41) PTPN1SIRT2SIRT1SIRT3MEN1
SCHEMBL14260784 0.80 PTPN1 (0.56) PTPN1SIRT2SIRT1SIRT3MRGPRX4
SCHEMBL6000615 0.80 PTPN2 (0.44) PTPN1SIRT2SIRT1SIRT3MRGPRX4
SCHEMBL4728519 0.80 PTPN1 (0.47) PTPN1SIRT2SIRT1SIRT3RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN1 2/4885SIRT2 2555/4885SIRT1 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.